ReviewFrontiers in oncology2024

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs.

Xiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.